Literature DB >> 27900020

MicroRNA-150 upregulation reduces osteosarcoma cell invasion and metastasis by downregulating Ezrin.

Ce Zhan1, Cheng Li1, Hao Zhang1, Hao Tang1, Fang Ji1, Su-Chi Qiao1, Wei-Dong Xu1, Zhi-Wei Wang1.   

Abstract

The present study aimed to investigate the effect of microRNA-150 (miRNA/miR-150) in osteosarcoma (OS) cell invasion and metastasis by the regulation of Ezrin. To compare the differences in the expression of miR-150 and Ezrin, cell models of OS metastasis were established by exogenous transfection of miR-150 on the basis of different expression levels of miR-150. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to estimate these expression levels. Ezrin expression was detected by western blot assay. Methylthiazolyldiphenyl-tetrazolium bromide assay was performed to determine cells proliferation. Cell invasion and migration were measured in vitro by Transwell migration assays. Detection of apoptosis adopted flow cytometry. The results of RT-qPCR showed that the miR-150 expression in OS F5M2 cells was significantly increased following exogenous transfection of miR-150 mimics, and the expression of miR-150 was positively correlated with the concentration of the miR-150 mimics. Western blot assay indicated that the Ezrin expression in the F5M2 cells was decreased with the exogenous overexpression of miR-150. Additionally, Transwell assays revealed that the overexpression of miR-150 significantly suppressed the invasion and metastasis ability of the F5M2 cells. miR-150 upregulation may reduce OS cell invasion and metastasis by downregulating the expression of Ezrin.

Entities:  

Keywords:  invasion and metastasis; microRNA-150; osteosarcoma

Year:  2016        PMID: 27900020      PMCID: PMC5103966          DOI: 10.3892/ol.2016.5046

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  36 in total

Review 1.  The therapeutic potential of microRNAs: disease modulators and drug targets.

Authors:  Ailbhe M McDermott; Helen M Heneghan; Nicola Miller; Michael J Kerin
Journal:  Pharm Res       Date:  2011-08-05       Impact factor: 4.200

Review 2.  MicroRNAs in stress signaling and human disease.

Authors:  Joshua T Mendell; Eric N Olson
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

Review 3.  MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects.

Authors:  Jinglei Miao; Song Wu; Zhi Peng; Mousumi Tania; Chaoyue Zhang
Journal:  Tumour Biol       Date:  2013-08

4.  MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1.

Authors:  Takehiko Yokobori; Shigemasa Suzuki; Naritaka Tanaka; Takanori Inose; Makoto Sohda; Akihiko Sano; Makoto Sakai; Masanobu Nakajima; Tatsuya Miyazaki; Hiroyuki Kato; Hiroyuki Kuwano
Journal:  Cancer Sci       Date:  2012-11-08       Impact factor: 6.716

5.  Height at diagnosis and birth-weight as risk factors for osteosarcoma.

Authors:  Lisa Mirabello; Ruth Pfeiffer; Gwen Murphy; Najat C Daw; Ana Patiño-Garcia; Rebecca J Troisi; Robert N Hoover; Chester Douglass; Joachim Schüz; Alan W Craft; Sharon A Savage
Journal:  Cancer Causes Control       Date:  2011-04-05       Impact factor: 2.506

6.  The role of microRNA-150 as a tumor suppressor in malignant lymphoma.

Authors:  A Watanabe; H Tagawa; J Yamashita; K Teshima; M Nara; K Iwamoto; M Kume; Y Kameoka; N Takahashi; T Nakagawa; N Shimizu; K Sawada
Journal:  Leukemia       Date:  2011-04-19       Impact factor: 11.528

7.  Secreted monocytic miR-150 enhances targeted endothelial cell migration.

Authors:  Yujing Zhang; Danqing Liu; Xi Chen; Jing Li; Limin Li; Zhen Bian; Fei Sun; Jiuwei Lu; Yuan Yin; Xing Cai; Qi Sun; Kehui Wang; Yi Ba; Qiang Wang; Dongjin Wang; Junwei Yang; Pingsheng Liu; Tao Xu; Qiao Yan; Junfeng Zhang; Ke Zen; Chen-Yu Zhang
Journal:  Mol Cell       Date:  2010-07-09       Impact factor: 17.970

8.  Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.

Authors:  Junfeng Zhu; Yupeng Feng; Zunfu Ke; Zheng Yang; Junyi Zhou; Xiaorong Huang; Liantang Wang
Journal:  Am J Pathol       Date:  2012-04-21       Impact factor: 4.307

9.  miRNA signatures associate with pathogenesis and progression of osteosarcoma.

Authors:  Kevin B Jones; Zaidoun Salah; Sara Del Mare; Marco Galasso; Eugenio Gaudio; Gerard J Nuovo; Francesca Lovat; Kimberly LeBlanc; Jeff Palatini; R Lor Randall; Stefano Volinia; Gary S Stein; Carlo M Croce; Jane B Lian; Rami I Aqeilan
Journal:  Cancer Res       Date:  2012-02-20       Impact factor: 12.701

10.  MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1.

Authors:  Xin Zhou; Min Wei; Wei Wang
Journal:  Biochem Biophys Res Commun       Date:  2013-07-18       Impact factor: 3.575

View more
  7 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  Research Progress of Exosome-Loaded miRNA in Osteosarcoma.

Authors:  Peng Yao; Yubao Lu; Zongyan Cai; Tianci Yu; Yuchen Kang; Yu Zhang; Xulong Wang
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 3.302

3.  LncRNA KASRT Serves as a Potential Treatment Target by Regulating SRSF1-Related KLF6 Alternative Splicing and the P21/CCND1 Pathway in Osteosarcoma: An In Vitro and In Vivo Study.

Authors:  Kai Chen; Cheng Li; Shuai Huang; Yu Chen; Xiaodong Zhu
Journal:  Front Oncol       Date:  2021-09-09       Impact factor: 6.244

Review 4.  Mass Spectrometric-Based Proteomics for Biomarker Discovery in Osteosarcoma: Current Status and Future Direction.

Authors:  Nutnicha Sirikaew; Dumnoensun Pruksakorn; Parunya Chaiyawat; Somchai Chutipongtanate
Journal:  Int J Mol Sci       Date:  2022-08-28       Impact factor: 6.208

5.  MicroRNA-542-3p inhibits oral squamous cell carcinoma progression by inhibiting ILK/TGF-β1/Smad2/3 signaling.

Authors:  Bin Qiao; Jing-Hua Cai; Alfred King-Yin Lam; Bao-Xia He
Journal:  Oncotarget       Date:  2017-08-07

6.  MicroRNA-16-5p overexpression suppresses proliferation and invasion as well as triggers apoptosis by targeting VEGFA expression in breast carcinoma.

Authors:  Yunhui Qu; Hongtao Liu; Xinquan Lv; Yuqiong Liu; Xiaojuan Wang; Min Zhang; Xiaqing Zhang; Yuenan Li; Qianqian Lou; Shenglei Li; Huixiang Li
Journal:  Oncotarget       Date:  2017-08-23

7.  Expression of microRNA-150 and its Target Gene IGF2BP1 in Human Osteosarcoma and their Clinical Implications.

Authors:  Lei Wang; Ailixiati Aireti; Aizezi Aihaiti; Kun Li
Journal:  Pathol Oncol Res       Date:  2018-09-15       Impact factor: 3.201

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.